4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8
enGene Holdings Inc. Enters Sales Agreement with Leerink Partners
Financial Results, Press Release
Announces Expanded $125 Million Debt Facility
Second Amendment to Loan Agreement with Hercules Capital Executed
Reports Full Year 2025 Financial Results and Provides Business Update
Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
Investor Presentation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Q1
Amended Annual Report
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence